Literature DB >> 4936142

Impairment of drug metabolism by disulfiram in man.

E S Vesell, G T Passananti, C H Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4936142     DOI: 10.1002/cpt1971125785

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  14 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Pharmacokinetics of inhaled carbon disulphide in rats in relation to its inhibitory effect on the side-chain oxidation of hexobarbital.

Authors:  K J Freundt; E Schnapp; W Dreher
Journal:  Int Arch Occup Environ Health       Date:  1975-08-14       Impact factor: 3.015

Review 3.  Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

Authors:  P Loiseau
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

4.  Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.

Authors:  C J van Boxtel; J T Wilson; S Lindgren; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

5.  Disulfiram implants: the right treatment but the wrong drug?

Authors:  S A Kline; E Kingstone
Journal:  Can Med Assoc J       Date:  1977-06-18       Impact factor: 8.262

6.  Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.

Authors:  M Døssing; H Pilsgaard; B Rasmussen; H E Poulsen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

8.  The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.

Authors:  T L Svendsen; M B Kristensen; J M Hansen; L Skovsted
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

Review 9.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 10.  Drug interactions with oral sulphonylurea hypoglycaemic drugs.

Authors:  J M Hansen; L K Christensen
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.